{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:17:26Z","timestamp":1783138646280,"version":"3.54.6"},"reference-count":10,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["YAKUGAKU ZASSHI"],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.1248\/yakushi.26-00007","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:21:27Z","timestamp":1782858087000},"page":"669-674","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Application Device Design on Scalp Delivery of Topical Minoxidil Formulations","\u30df\u30ce\u30ad\u30b7\u30b8\u30eb\u5916\u7528\u5264\u306b\u304a\u3051\u308b\u5bb9\u5668\u8a2d\u8a08\u306e\u9055\u3044\u304c\u982d\u76ae\u5230\u9054\u91cf\u306b\u53ca\u307c\u3059\u5f71\u97ff"],"prefix":"10.1248","volume":"146","author":[{"given":"Ayano","family":"Kojima","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Josai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Todo","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Josai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Inoue","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Josai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syuuhei","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Josai University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Todo H., Saito M., Suzuki H., Inoue Y., Takayama K., Sugibayashi K., <i>Yakuzaigaku<\/i>, <b>81<\/b>, 111\u2013120 (2021)."},{"key":"2","unstructured":"2) Murakami M., Nakaya M., Yasuda M., Amano M., <i>Jpn. J. Drug Inform.<\/i>, <b>18<\/b>, 209\u2013213 (2016)."},{"key":"3","unstructured":"3) Scientific Committee on Consumer Safety (SCCS). \u201cOPINION ON reaction products of oxidative hair dye ingredients formed during hair dyeing processes.\u201d: \u3008https:\/\/ec.europa.eu\/health\/scientific_committees\/consumer_safety\/docs\/sccs_o_037.pdf?utm_source=chatgpt.com\u3009, cited 27 November, 2025."},{"key":"4","unstructured":"4) Ministry of Health, Labour and Welfare (MHLW), Japan. \u201cGuidance on <i>In Vitro<\/i> Skin Permeation Testing (<i>In Vitro<\/i> Percutaneous Absorption Testing) for Safety Evaluation of Cosmetics and Quasi-drugs.\u201d: \u3008https:\/\/www.mhlw.go.jp\/web\/t_doc?dataId=00tc2301&amp;dataType=1&amp;pageNo=1\u3009, cited 26 November, 2025."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Lehman P. A., Raney S. G., Franz T. J., <i>Skin Pharmacol. Physiol.<\/i>, <b>24<\/b>, 224\u2013230 (2011).","DOI":"10.1159\/000324884"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ntshingila S., Oputu O., Arowolo A. T., Khumalo N. P., <i>JAAD Int.<\/i>, <b>13<\/b>, 150\u2013158 (2023).","DOI":"10.1016\/j.jdin.2023.07.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Daniels G., Fraser A., Westgate G. E., <i>Int. J. Cosmet. Sci.<\/i>, <b>45<\/b>, 50\u201361 (2023).","DOI":"10.1111\/ics.12819"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Park H. U., Chung K. B., Kim D. Y., <i>JAAD Int.<\/i>, <b>15<\/b>, 121\u2013126 (2024).","DOI":"10.1016\/j.jdin.2024.02.005"},{"key":"9","unstructured":"9) European Medicines Agency (EMA). \u201cRequirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD)-Scientific guideline.\u201d: \u3008https:\/\/www.ema.europa.eu\/en\/requirements-demonstrating-therapeutic-equivalence-between-orally-inhaled-products-oip-asthma-chronic-obstructive-pulmonary-disease-copd-scientific-guideline\u3009, cited 26 November, 2025."},{"key":"10","unstructured":"10) Ministry of Health, Labour and Welfare (MHLW), Japan. \u201cBasic concept for evaluation of bioequivalence for generic dry powder inhalation products.\u201d: \u3008https:\/\/www.mhlw.go.jp\/web\/t_doc?dataId=00tc1656&amp;dataType=1&amp;pageNo=1\u3009, cited 26 November, 2025."}],"container-title":["YAKUGAKU ZASSHI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/146\/7\/146_26-00007\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:32:40Z","timestamp":1783135960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/146\/7\/146_26-00007\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/yakushi.26-00007","relation":{},"ISSN":["0031-6903","1347-5231"],"issn-type":[{"value":"0031-6903","type":"print"},{"value":"1347-5231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"26-00007"}}